December 29, 2021
Biomarker-driven prescribing is paramount in key oncology indications. The use of biomarkers is entrenched in indications such as non-small-cell lung cancer (NSCLC) and bladder cancer and is…
December 15, 2021
May 15, 2021
June 17, 2020
February 21, 2020
December 19, 2019
October 30, 2019
December 20, 2018
May 31, 2018
December 20, 2017